[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
September 4, 2002

Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)—Correction

JAMA. 2002;288(9):1064. doi:10.1001/jama.288.9.1064

Numbers Reversed. In the Original Contribution entitled "Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy: Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II)" published in the July 3, 2002, issue of THE JOURNAL (2002;288:49-57), 2 numbers were reversed. On page 53, the fourth sentence in the "Adjusted and per Protocol Analyses" section should read "By the end of follow-up in HERS II, the proportion of statin use was 63% for the hormone group and 67% for the placebo group (P = .01)."

×